← All companies
AXSM annual net income
Axsome Therapeutics, Inc.
AXSM - CIK 0001579428
Market cap$13.13 B
Rank#799
SEC filings634
Axsome Therapeutics, Inc. net income by year
Axsome Therapeutics, Inc. (AXSM) reported net income of -$183.17M for fiscal year 2025, as filed in its audited annual report with the SEC.
AXSM net income 2014-2025
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$183.17M | +36.2% |
| FY 2024 | -$287.22M | -20.1% |
| FY 2023 | -$239.24M | -27.8% |
| FY 2022 | -$187.13M | -43.5% |
| FY 2021 | -$130.40M | -26.7% |
| FY 2020 | -$102.90M | -50.6% |
| FY 2019 | -$68.35M | -120.7% |
| FY 2018 | -$30.97M | -7.0% |
| FY 2017 |
Net Income of similar companies
Frequently asked questions
How much profit does Axsome Therapeutics, Inc. make?
Axsome Therapeutics, Inc. (AXSM) reported net income of -$183.17M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has Axsome Therapeutics, Inc.'s net income changed over time?
Between fiscal 2014 and fiscal 2025, Axsome Therapeutics, Inc.'s net income declined from -$6.00M to -$183.17M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.